TD-8236

DRUG2 trials

Sponsors

Theravance Biopharma

Conditions

Asthma

Phase 1

Single and Multiple Ascending Dose Study of TD-8236 by Inhalation

CompletedNCT03652038

Theravance BiopharmaAsthma

Start: 2018-11-07End: 2020-07-13Updated: 2021-09-30

Phase 2

Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response

CompletedNCT04150341

Theravance BiopharmaAsthma

Start: 2019-11-06End: 2020-09-03Updated: 2022-03-18